McKesson Corporation (MCK)
NYSE · Healthcare · Medical Distribution
McKesson Corporation is a Healthcare company with a market capitalization of $89.39B, a trailing P/E ratio of 19.9, and a dividend yield of 0.42%.
5-Year Price History
Latest Annual Financials · FY ending March 31, 2026
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q4 2026 | May 7, 2026 | $11.69 | $11.57 | +1.0% |
| Q3 2025 | February 4, 2026 | $9.34 | $9.27 | +0.8% |
| Q2 2025 | November 5, 2025 | $9.86 | $9.05 | +8.9% |
| Q1 2025 | August 6, 2025 | $8.26 | $8.15 | +1.4% |
| Q4 2025 | May 8, 2025 | $10.12 | $9.83 | +2.9% |
| Q3 2024 | February 5, 2025 | $8.03 | $7.99 | +0.5% |
Other Medical Distribution Stocks
Frequently Asked Questions
What is McKesson Corporation's market cap?
As of June 29, 2026, McKesson Corporation (MCK) has a market capitalization of $89.39B.
What is McKesson Corporation's P/E ratio?
McKesson Corporation trades at a trailing price-to-earnings (P/E) ratio of 19.9. Its forward P/E is 17.2.
Does McKesson Corporation pay a dividend?
Yes — McKesson Corporation pays a dividend yielding 0.42%, an annual payout of $3.17 per share.
What sector is MCK in?
McKesson Corporation is in the Healthcare sector, specifically the Medical Distribution industry.
What was McKesson Corporation's revenue?
In its latest reported fiscal year (ending March 31, 2026), McKesson Corporation reported revenue of $403.43B and net income of $4.76B.
Ask your own questions about MCK
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.